CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | +150.0% | 1,800 | +80.0% | 0.00% | – |
| Q3 2019 | $4,000 | -80.0% | 1,000 | -65.2% | 0.00% | – |
| Q2 2019 | $20,000 | -79.2% | 2,870 | -79.3% | 0.00% | -100.0% |
| Q1 2019 | $96,000 | +9.1% | 13,850 | -8.0% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | +131.6% | 15,050 | +201.0% | 0.00% | – |
| Q3 2018 | $38,000 | +2.7% | 5,000 | -16.7% | 0.00% | – |
| Q2 2018 | $37,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | -47.1% | 6,000 | -38.6% | 0.00% | -100.0% |
| Q4 2017 | $70,000 | +20.7% | 9,770 | +21.1% | 0.00% | 0.0% |
| Q3 2017 | $58,000 | +141.7% | 8,070 | +106.9% | 0.00% | – |
| Q2 2017 | $24,000 | -25.0% | 3,900 | 0.0% | 0.00% | – |
| Q1 2017 | $32,000 | +10.3% | 3,900 | +14.7% | 0.00% | – |
| Q4 2016 | $29,000 | +866.7% | 3,400 | +750.0% | 0.00% | – |
| Q3 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |